Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
Clinical trial NCT00940121 · COMPLETED
Trial details
- NCT number
- NCT00940121
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-30
- Primary completion
- 2009-07-13
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.